MAZE vs TRMB · rev $20.0M vs P/E 26, rev $1.91B
Maze Therapeutics, Inc. Common Stock (MAZE) versus Trimble Inc (TRMB) — a side-by-side from cached financials, not a winner call.
Maze Therapeutics, Inc. Common Stock (MAZE) is a biotechnology company listed on US.
Trimble Inc (TRMB) is a scientific & technical instruments company listed on NASDAQ.
Latest reported MAZE revenue for 2026-06-30 was $20.0M. Net income was -$68.9M. Revenue was up 0.0% from 2026-03-31 to 2026-06-30. MAZE currently screens at market cap $525.3M.
Latest reported TRMB revenue for 2026-07-03 was $1.91B. Net income was -$372.8M. TRMB currently screens at market cap $11.39B and trailing P/E 25.6.
MAZE currently screens at market cap $525.3M. TRMB currently screens at market cap $11.39B and trailing P/E 25.6.
Not investment advice. Open the MAZE and TRMB stock pages for the full models.
Not investment advice.